Entering text into the input field will update the search result below

Miragen Therapeutics, Inc. (MGEN) CEO William Marshall on Q2 2018 Results - Earnings Call Transcript

Aug. 07, 2018 10:30 PM ETViridian Therapeutics, Inc. (VRDN)
SA Transcripts profile picture
SA Transcripts

Miragen Therapeutics, Inc. (MGEN) Q2 2018 Earnings Conference Call August 7, 2018 4:30 PM ET


Daniel Ferry - LifeSci Advisors , LLC

William Marshall - President and CEO

Jason Leverone - CFO


Jonathan Miller - Evercore ISI

Liana Moussatos - Wedbush Securities

Yun Wang - Jefferies


Good afternoon and welcome to the Miragen Therapeutics Second Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded.

I'd now like to turn the conference over to Mr. Daniel Ferry from LifeSci Advisors. Please go ahead

Daniel Ferry

Thank you, and good afternoon, everyone. On the call today are Miragen's President and Chief Executive Officer, Bill Marshall; Chief Financial Officer, Jason Leverone; Executive Vice President of Research and Development, Paul Rubin; and Chief Business Officer, Adam Levy.

Before we begin, I would like to remind everyone that this conference call and webcast will contain forward-looking statements about the company. These statements are subject to risks and uncertainties that could cause actual results to differ. Please note that these forward-looking statements reflect our opinions only as of the date of this call. We will undertake no obligation to revise or publicly release the results of any revisions to these forward-looking statements in light of new information or future events. Factors that could cause actual results or outcomes to differ materially from those expressed in or implied by such forward-looking statements are discussed in greater detail in our most recent filings on Form 10-K and our other periodic reports on Forms 10-Q and 8-K filed with the SEC.

I would now like to turn the call over to Bill Marshall, President and Chief Executive

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.